These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21141306)

  • 41. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pharmaceutical grants: an overview].
    Simonsen SA
    Theriaca; 1989 Oct; 24():3-255. PubMed ID: 11629732
    [No Abstract]   [Full Text] [Related]  

  • 43. [The development of the pharmaceutical industry in Berlin].
    Alcer G
    Pharmazie; 1987 Nov; 42(11):774-80. PubMed ID: 3325996
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmaceutical high profits: the value of R&D, or oligopolistic rents?
    Spitz J; Wickham M
    Am J Econ Sociol; 2012; 71(1):1-36. PubMed ID: 22319815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

  • 46. The treatment: why is it so difficult to develop drugs for cancer?
    Gladwell M
    New Yorker; 2010 May; ():68-77. PubMed ID: 21692364
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmaceuticals: drug importation--2005. End of Year Issue Brief.
    Varma P; Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708457
    [No Abstract]   [Full Text] [Related]  

  • 48. US drug sales continue to rise.
    Gottlieb S
    BMJ; 2003 Mar; 326(7388):518. PubMed ID: 12623895
    [No Abstract]   [Full Text] [Related]  

  • 49. [The historical research on the pharmaceutical industry in France and abroad].
    Ruffat M
    Rev Hist Pharm (Paris); 1995; 42(305):187-95. PubMed ID: 11640461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug Pricing Regulation Pushed From Many Sides.
    Kirkner RM
    Manag Care; 2016 Jan; 25(1):14-5. PubMed ID: 26882623
    [No Abstract]   [Full Text] [Related]  

  • 51. Can complexity be commercialized?
    Mack GS
    Nat Biotechnol; 2004 Oct; 22(10):1223-9. PubMed ID: 15470456
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmaceutical impact on cost reduction in German hospitals prior to World War II.
    Helmstädter A
    Pharm Hist; 1997; 39(4):148-53. PubMed ID: 11619924
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacy through the ages. Origins of gelatin capsules.
    Worthen DB
    J Am Pharm Assoc (2003); 2004; 44(1):9. PubMed ID: 14965145
    [No Abstract]   [Full Text] [Related]  

  • 54. Risks and benefits of importing prescription medications from lower-income countries.
    Dhalla IA; Detsky AS
    JAMA; 2008 Sep; 300(12):1453-5. PubMed ID: 18812537
    [No Abstract]   [Full Text] [Related]  

  • 55. Sources of drug market data [1953].
    Southern WA
    Pharm Hist; 2002; 44(2):77-82. PubMed ID: 12240682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    Health Care Law Mon; 2007 Aug; ():3-12. PubMed ID: 17955590
    [No Abstract]   [Full Text] [Related]  

  • 57. How insurers' bargaining power affects drug prices in Medicare Part D.
    Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274
    [No Abstract]   [Full Text] [Related]  

  • 58. CETA: a win for Canada or European pharma?
    Webster PC
    CMAJ; 2014 Oct; 186(15):E565-6. PubMed ID: 25267767
    [No Abstract]   [Full Text] [Related]  

  • 59. Making the move into drug sales.
    Willerroider M
    Nature; 2004 Jul; 430(6998):486-7. PubMed ID: 15269778
    [No Abstract]   [Full Text] [Related]  

  • 60. [Not Available].
    Zerobin C
    Veroff Schweiz Ges Gesch Pharm; 1998; 17():17-34. PubMed ID: 11637111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.